Status:
COMPLETED
Magnetoencephalographic (MEG) Localization of Ramelteon's Effects on Brain Function and Cortical Arousal in Insomnia
Lead Sponsor:
Henry Ford Health System
Collaborating Sponsors:
Takeda Pharmaceuticals North America, Inc.
Conditions:
Insomnia
Eligibility:
All Genders
18-55 years
Brief Summary
The present protocol will utilize simultaneous recording of brain activity during attention and memory tasks in insomnia participants after ramelteon vs. zolpidem vs. placebo administration. The inves...
Detailed Description
The proposed research has two specific aims: 1) demonstrate that ramelteon has no effect on event related potential components that reflect basic sensory processes (P1 and N1), and will not impair att...
Eligibility Criteria
Inclusion
- Healthy individuals with no secondary condition to insomnia.
Exclusion
- Healthy individuals with no insomnia.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00688025
Start Date
May 1 2008
End Date
March 1 2010
Last Update
March 31 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Hospital Sleep Disorders & Research Center
Detroit, Michigan, United States, 48202